Microbioreactor Design for Eukaryotic Cell-Based Biomedical Applications
July 2026
in “
Frontiers in Bioengineering and Biotechnology
”
eukaryotic cell-based biomedicine microbioreactor cell therapies protein production organoid engineering microfluidics T-cell manufacturing perfusion-based microbioreactors oxygenation tissue morphogenesis extracellular matrix remodeling developmental signaling automation therapeutic pipelines personalized medicine
Studysummary This mini-review reports that advances in microbioreactor technology, particularly with microfluidics, significantly enhance eukaryotic cell-based biomedicine by improving productivity, scalability, and reproducibility in applications like CAR T-cell manufacturing and organoid growth, though challenges in scalability and material selection remain.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on frontiersin.org →